98%
921
2 minutes
20
White spot syndrome virus (WSSV), the causative agent of white spot disease, remains a serious threat to crustacean aquaculture. Infecting a wide range of crustaceans, host species exhibit varying susceptibility and mortality rates. Mud crabs, Scylla serrata, a high-value aquaculture commodity across the Indo-Pacific region, are known to be relatively resistant to WSSV. However, there is limited information on the progression of WSSV infection in the species which can provide insight into mechanisms of resistance. Employing a time course experimental challenge of S. serrata with WSSV, this study characterized viral load dynamics in juveniles over a period of 144 h post infection (hpi) in relation to (1) disease outcomes (survival or mortality); (2) distribution among tissue types (gills, gut, hepatopancreas, and hemolymph); and (3) variability between two different juvenile cohorts. Viral load progression suggests that WSSV resistance in mud crabs may be due to two distinct mechanisms. One mechanism involves the capability of S. serrata for viral clearance following active viral replication. Viral growth in S. serrata demonstrates three phases: early stage or onset characterized by minimal change in viral load (0 to 24-hpi), logarithmic stage of active replication with rapid increase in viral copy number (24 to 72-hpi), with the third phase (96-144 hpi), exhibiting differential patterns with infection outcome. Dead crabs exhibited a plateau phase where viral loads remained similar to peak levels, while crabs that were still alive beyond 96 hpi exhibited a resolution phase, characterized by reduction in viral load, returning to non-infected levels. Another apparent mechanism for WSSV resistance involved overall inhibition of replication, with recalcitrant individuals exhibiting markedly low viral loads at expected logarithmic infection phase timepoints (48-72 hpi). This study also revealed tissue tropism of WSSV in S. serrata. Gills appear to be the primary site of WSSV replication, exhibiting the highest viral load from the early to peak stages of infection compared to other tissue types such as the gut, hepatopancreas, and hemolymph. The establishment of viral load curves to track the progression of WSSV infection, and characterization of viral abundance across different tissues through the course of infection, represents novel information that has key implications on the role of S. serrata as carriers/vectors of WSSV. This may have practical implications for disease mitigation measures for aquaculture facilities, and development of new strategies to prevent and reduce pathogen infection in mud crab to support sustainable aquaculture production.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jip.2025.108450 | DOI Listing |
J Invertebr Pathol
September 2025
The Marine Science Institute, College of Science, University of the Philippines Diliman, Quezon City 1101, Philippines.
White spot syndrome virus (WSSV), the causative agent of white spot disease, remains a serious threat to crustacean aquaculture. Infecting a wide range of crustaceans, host species exhibit varying susceptibility and mortality rates. Mud crabs, Scylla serrata, a high-value aquaculture commodity across the Indo-Pacific region, are known to be relatively resistant to WSSV.
View Article and Find Full Text PDFFish Shellfish Immunol
September 2025
College of Marine Sciences, South China Agricultural University, Guangzhou, 510642, China; Nansha-South China Agricultural University Fishery Research Institute, Guangzhou, 511464, China. Electronic address:
Sea perch is one of the most important fish species farmed in China. However, the frequent outbreak of viral diseases induced by sea perch iridovirus (SPIV) always caused high mortality and heavy economic losses in sea perch aquaculture. Up to now, no effective countermeasures against SPIV infection have been established.
View Article and Find Full Text PDFOcul Immunol Inflamm
September 2025
Manchester Royal Eye Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
Purpose: To report a rare case of bilateral necrotising retinitis caused by a potentially novel human adenovirus D (HAdV-D) in a post-bone marrow transplant patient and to highlight the diagnostic challenges and therapeutic role of intravenous cidofovir, alongside a review of previously reported cases of human adenovirus (HAdV) retinitis.
Methods: Retrospective case report.
Results: A 60-year-old man with a history of acute myeloid leukaemia, in remission post-bone marrow transplant, presented with bilateral hypertensive granulomatous panuveitis and necrotising retinitis.
Front Public Health
September 2025
Department of Family and Community Medicine, Penn State University College of Medicine, Hershey, PA, United States.
Background: The World Health Organization recommends at-home management of mild COVID-19. While our preliminary evaluation provided evidence for saline nasal irrigation (SNI) and gargling in COVID-19, an update and risk-benefit assessment for self-care in Omicron infection is warranted, from treatment and preparedness perspectives, as new SARS-CoV-2 variants continuously emerge, while symptoms overlap with those of common colds and other upper respiratory tract infections.
Methods: Systematic literature searches for preclinical and clinical studies involving Omicron infection and saline, bias assessment, and review of outcomes (benefits, risks).
Front Oncol
August 2025
Department of Surgical Oncology, Central Hospital of Guangdong Provincial Nongken, Zhanjiang, Guangdong, China.
Microsatellite-stable (MSS) rectal adenocarcinoma remains a therapeutic challenge, particularly in patients with complicating factors such as chronic hepatitis B virus (HBV) infection. Advances in immunotherapy, including immune checkpoint inhibitors (ICIs), have introduced new opportunities to improve the treatment outcomes in this subset, yet their application in HBV-positive cancer patients is less well understood. Here we report the case of a 46-year-old female with MSS locally advanced rectal adenocarcinoma and active HBV infection, successfully treated with cmFOLFOXIRI combined with camrelizumab as neoadjuvant therapy.
View Article and Find Full Text PDF